Zalaris ASA (ZAL)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 102.00 |
|---|---|
| 52-week range | 70.80 – 130.00 |
| Return, 1 month / 3 months | +2.0% / +0.5% |
| Return, 1 year / 3 years | +17.5% / +149.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 51.1% |
| Worst drawdown (1 year) | -24.4% |
| Average daily value traded | 0.21M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zalaris ASA is a Norwegian company that provides payroll and human resources services to businesses. It handles payroll processing and HR administration for client organisations, and it also offers consulting and support around human resources software systems. Its customers are employers that choose to outsource parts of their payroll and personnel work rather than manage it internally. The company is based in Norway and works with clients in several European countries.
On this site Zalaris ASA appears as a stock on the Oslo Stock Exchange (Norway), code ZAL, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zalaris ASA (ZAL) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 102.00 on 22 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 160 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.5% and over the last three months it rose 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.5% | ||
| From 52-week high | -21.2% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.5% | ||
| 6-month return | 3.4% | ||
| 12-month return, skipping the last month | 15.2% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.4% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.21M NOK | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −21.2% |
|---|---|
| 1 month | +2.0% |
| 3 months | +0.5% |
| 6 months | +3.4% |
| 1 year | +17.5% |
| 3 years | +149.7% |
| 5 years | +99.0% |
Signals
| 50-day / 200-day average | 104.63 / 96.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 May 2025 | NOK 0.9000 |
| 24 May 2023 | NOK 0.5000 |
| 20 May 2022 | NOK 0.3500 |
| 21 May 2021 | NOK 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.